/
Other
Complication
80
Pipeline Programs↗
51
Active Trials↗
42
Companies Involved↗
Complication is a moderately active landscape with 80 programs across 42 companies. The most active players are Jiangxi Qingfeng Pharmaceutical Co. Ltd., MaaT Pharma, NextCell Pharma Ab. 7 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical69
Phase 11
Phase 23
Phase 37
Approved
No programs
Analysis
Modality Breakdown
95%
Small molecule
69 of 73 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 73 classified programs, each share of the total. Modality classified for 100% of 80 pipeline programs.
Analysis
Trial Status
286
clinical trials
Completed142 · 50%
Unknown status53 · 19%
Recruiting32 · 11%
Terminated25 · 9%
Withdrawn13 · 5%
Not yet recruiting11 · 4%
Other10 · 3%
Clinical Trials
Trial Activity
286 trials
Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary Complications
Recruiting·—·N/A·NCT06865040·266 enrolled
Efficacy of Ozone Therapy in Reducing Complications Following Impacted Mandibular Third-molar Surgery
Recruiting·—·Phase 3·NCT06802354·20 enrolled
Page 1 of 20
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)